The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kozlowski, S.
Right arrow Articles by Margulies, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kozlowski, S.
Right arrow Articles by Margulies, D. H.

The Journal of Immunology, Vol 151, Issue 8 4033-4044, Copyright © 1993 by American Association of Immunologists


ARTICLES

Multiple pathways are involved in the extracellular processing of MHC class I-restricted peptides

S Kozlowski, M Corr, M Shirai, LF Boyd, CD Pendleton, JA Berzofsky and DH Margulies
Molecular Biology Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.

T cell stimulation by certain class I-restricted antigenic peptides, such as the HIV 1 gp160-derived peptide, P18, requires peptide processing by angiotensin-1 converting enzyme (ACE) in FCS. We observed that longer versions of P18 and the murine cytomegalovirus pp89-derived core peptide, pMCMV, which could stimulate T cell hybridomas in FCS, were not as sensitive to the ACE inhibitor captopril as P18. Using cell- free soluble murine class I MHC molecules and protease inhibitors, we found that there are pathways of differing efficiency that use enzymes other than ACE for the proteolytic processing of peptides in serum. The kinetics of the generation of T cell stimulatory activity among P18 variant peptides in serum differed with peptide length, and with the nature of amino and COOH-terminal extensions. Such processing occurs in human plasma as well as in FCS. The understanding of this processing, its kinetics, and its inhibitors can lead to better design of peptide- based therapies, including vaccines.


This article has been cited by other articles:


Home page
J. Immunol.Home page
H. Jackson, N. Dimopoulos, N. A. Mifsud, T. Y. Tai, Q. Chen, S. Svobodova, J. Browning, I. Luescher, L. Stockert, L. J. Old, et al.
Striking Immunodominance Hierarchy of Naturally Occurring CD8+ and CD4+ T Cell Responses to Tumor Antigen NY-ESO-1
J. Immunol., May 15, 2006; 176(10): 5908 - 5917.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Samino, D. Lopez, S. Guil, L. Saveanu, P. M. van Endert, and M. Del Val
A Long N-terminal-extended Nested Set of Abundant and Antigenic Major Histocompatibility Complex Class I Natural Ligands from HIV Envelope Protein
J. Biol. Chem., March 10, 2006; 281(10): 6358 - 6365.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Trivedi, R. Y. Williams, R. J. O'Reilly, and G. Koehne
Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy
Blood, April 1, 2005; 105(7): 2793 - 2801.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. M. Hill, T. Kasliwal, E. Schwarz, A. M. Hebert, T. Chen, E. Gubina, L. Zhang, and S. Kozlowski
A Dominant Negative Mutant beta 2-Microglobulin Blocks the Extracellular Folding of a Major Histocompatibility Complex Class I Heavy Chain
J. Biol. Chem., February 14, 2003; 278(8): 5630 - 5638.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. A. Lyman, H.-G. Lee, B. S. Kang, H.-K. Kang, and B. S. Kim
Capsid-Specific Cytotoxic T Lymphocytes Recognize Three Distinct H-2Db-Restricted Regions of the BeAn Strain of Theiler's Virus and Exhibit Different Cytokine Profiles
J. Virol., March 7, 2002; 76(7): 3125 - 3134.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Lopez, Y. Samino, U. H. Koszinowski, and M. Del Val
HIV Envelope Protein Inhibits MHC Class I Presentation of a Cytomegalovirus Protective Epitope
J. Immunol., October 15, 2001; 167(8): 4238 - 4244.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Geginat, S. Schenk, M. Skoberne, W. Goebel, and H. Hof
A Novel Approach of Direct Ex Vivo Epitope Mapping Identifies Dominant and Subdominant CD4 and CD8 T Cell Epitopes from Listeria monocytogenes
J. Immunol., February 1, 2001; 166(3): 1877 - 1884.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Lopez, B. C. Gil-Torregrosa, C. Bergmann, and M. Del Val
Sequential Cleavage by Metallopeptidases and Proteasomes Is Involved in Processing HIV-1 ENV Epitope for Endogenous MHC Class I Antigen Presentation
J. Immunol., May 15, 2000; 164(10): 5070 - 5077.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ayyoub, H. Mazarguil, B. Monsarrat, B. Van den Eynde, and J. E. Gairin
A Structure-based Approach to Designing Non-natural Peptides That Can Activate Anti-melanoma Cytotoxic T Cells
J. Biol. Chem., April 9, 1999; 274(15): 10227 - 10234.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R.-F. Wang, S. L. Johnston, G. Zeng, S. L. Topalian, D. J. Schwartzentruber, and S. A. Rosenberg
A Breast and Melanoma-Shared Tumor Antigen: T Cell Responses to Antigenic Peptides Translated from Different Open Reading Frames
J. Immunol., October 1, 1998; 161(7): 3596 - 3606.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. J. Shields, N. Assefi, W. Hodgson, E. J. Kim, and R. K. Ribaudo
Characterization of the Interactions Between MHC Class I Subunits: A Systematic Approach for the Engineering of Higher Affinity Variants of {beta}2-Microglobulin
J. Immunol., March 1, 1998; 160(5): 2297 - 2307.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.